← العودة إلى الصفحة الرئيسية
أوروبا · وكالات وأخبار لحظية · Reuters Business

Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle

نشره Reuters Business · المملكة المتحدة منذ 10 س
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Reuters Business

ملخص مفصل

Takeda said on Thursday its narcolepsy pill, the first treatment to target the underlying cause of the rare sleep disorder, is ​now available in the US after a Drug Enforcement…

اقرأ المقال كاملًا على Reuters Business سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.reuters.com)

يستحق القراءة أيضًا

Anadolu Agency

Nvidia CEO Jensen Huang resigns amid board investigation

 TASS

People's rights are priority in territorial dispute regarding Ukraine conflict — Putin

 Reuters Technology

Concentrate AI Launches HIPAA-Compliant AI Gateway With One BAA to Simplify Model Access and Reduce Inference Costs

 Reuters Breakingviews

Concentrate AI Launches HIPAA-Compliant AI Gateway With One BAA to Simplify Model Access and Reduce Inference Costs

 Reuters Commodities

Concentrate AI Launches HIPAA-Compliant AI Gateway With One BAA to Simplify Model Access and Reduce Inference Costs

 Reuters

From SpaceX to Anthropic, markets have a new playbook for mega-share debuts